Medical News

Provectus Pharmaceuticals, Inc. announced preliminary results of its Phase 1 clinical trial of Provecta for the therapy of metastatic melanoma, the most aggressive form of skin cancer. Provecta demonstrated minimal side effects, significant efficacy and bystander effect on melanoma tumors in stage III patients. The study reviewed safety and efficacy of Provecta in a total of 20 subjects at two sites in Australia……..

Original post by Health news from medicineworld.org

Provectus Pharmaceuticals, Inc. announced preliminary results of its Phase 1 clinical trial of Provecta for the therapy of metastatic melanoma, the most aggressive form of skin cancer. Provecta demonstrated minimal side effects, significant efficacy and bystander effect on melanoma tumors in stage III patients. The study reviewed safety and efficacy of Provecta in a total of 20 subjects at two sites in Australia……..

Original post by Health news from medicineworld.org